索引超出了数组界限。 文章摘要
|本期目录/Table of Contents|

[1]慕婷婷,邓爱云.药物负荷超声心动图结合超声新技术评价非阻塞性冠状动脉微血管疾病[J].国际心血管病杂志,2024,02:84-88.
点击复制

药物负荷超声心动图结合超声新技术评价非阻塞性冠状动脉微血管疾病(PDF)

《国际心血管病杂志》[ISSN:1006-6977/CN:61-1281/TN]

期数:
2024年02期
页码:
84-88
栏目:
综述
出版日期:
2024-03-25

文章信息/Info

Title:
-
作者:
慕婷婷; 邓爱云
730099 兰州大学第一临床医学院（慕婷婷）；730013 兰州大学第一医院心内彩超室（邓爱云）
Author(s):
-
关键词:
药物负荷超声心动图; 超声新技术; 冠状动脉; 微血管疾病
Keywords:
-
分类号:
-
DOI:
10.3969/j.issn.1673-6583.2024.02.006
文献标识码:
-
摘要:
非阻塞性冠状动脉微血管疾病（CMVD）广泛存在于各种心血管疾病中，早期识别、尽早干预非阻塞性CMVD对于减轻其严重并发症、改善长期预后至关重要。超声新技术的不断更新与发展使得准确、定量、全面地评估微血管缺血成为可能，进而提高了非阻塞性CMVD的检出率。该文介绍药物负荷超声心动图结合超声新技术评价非阻塞性CMVD的研究进展。
Abstract:
-

参考文献/References

[1] Berry C, Sidik N, Pereira AC, et al. Small-vessel disease in the heart and brain: current knowledge, unmet therapeutic need, and future directions[J]. J Am Heart Assoc, 2019, 8(3):e011104.
[2] Masi S, Rizzoni D, Taddei S, et al. Assessment and pathophysiology of microvascular disease: recent progress and clinical implications[J]. Eur Heart J, 2021, 42(26):2590-2604.
[3] 张运, 陈韵岱, 傅向华, 等. 冠状动脉微血管疾病诊断和治疗的中国专家共识[J]. 中国循环杂志, 2017, 32(5):421-430.
[4] Yang N, Su YF, Li WW, et al. Microcirculation function assessed by adenosine triphosphate stress myocardial contrast echocardiography and prognosis in patients with nonobstructive coronary artery disease[J]. Medicine (Baltimore), 2019, 98(27):e15990.
[5] Herrmann J, Kaski JC, Lerman A. Coronary microvascular dysfunction in the clinical setting: from mystery to reality[J]. Eur Heart J, 2012, 33(22):2771-2782.
[6] Radico F, Zimarino M, Fulgenzi F, et al. Determinants of long-term clinical outcomes in patients with angina but without obstructive coronary artery disease: a systematic review and meta-analysis[J]. Eur Heart J, 2018, 39(23):2135-2146.
[7] Padro T, Manfrini O, Bugiardini R, et al. ESC Working Group on Coronary Pathophysiology and Microcirculation position paper on 'coronary microvascular dysfunction in cardiovascular disease'[J]. Cardiovasc Res, 2020, 116(4):741-755.
[8] Lindemann H, Petrovic I, Hill S, et al. Biopsy-confirmed endothelial cell activation in patients with coronary microvascular dysfunction[J]. Coron Artery Dis, 2018, 29(3):216-222.
[9] Del Buono MG, Montone RA, Camilli M, et al. Coronary microvascular dysfunction across the spectrum of cardiovascular diseases: JACC state-of-the-art review[J]. J Am Coll Cardiol, 2021, 78(13):1352-1371.
[10] Heusch G, Skyschally A, Kleinbongard P. Coronary microembolization and microvascular dysfunction[J]. Int J Cardiol, 2018, 258:17-23.
[11] Lancellotti P, Pellikka PA, Budts W, et al. The clinical use of stress echocardiography in non-ischaemic heart disease: recommendations from the European Association of Cardiovascular Imaging and the American Society of Echocardiography[J]. J Am Soc Echocardiogr, 2017, 30(2):101-138.
[12] Gaibazzi N, Rigo F, Lorenzoni V, et al. Association of coronary computed tomography angiography and stress echocardiography with long-term cardiac outcome: a comparison study[J]. J Clin Med, 2023, 12(3):903.
[13] Picano E, Pellikka PA. Stress echo applications beyond coronary artery disease[J]. Eur Heart J, 2014, 35(16):1033-1040.
[14] Schroder J, Prescott E. Doppler echocardiography assessment of coronary microvascular function in patients with angina and no obstructive coronary artery disease[J]. Front Cardiovasc Med, 2021, 8:723542.
[15] Li X, He S, Zhang YS, et al. Resting myocardial contrast echocardiography for the evaluation of coronary microcirculation dysfunction in patients with early coronary artery disease[J]. Clin Cardiol, 2016, 39(8):453-458.
[16] Nesto RW, Kowalchuk GJ. The ischemic cascade: temporal sequence of hemodynamic, electrocardiographic and symptomatic expressions of ischemia[J]. Am J Cardiol, 1987, 59(7):23C-30C.
[17] 朱艳艳, 丁明岩, 冀威, 等. 非冠状动脉梗阻性缺血性心脏病冠状动脉微血管功能障碍与左室收缩功能的相关性[J]. 临床超声医学杂志, 2021, 23(7):511-515.
[18] Zhao L, Wang QH, Xu PL, et al. Evaluation of left ventricular function in ischemia with non-obstructive coronary arteries:a research based on adenosine stress myocardial contrast echocardiography[J]. Int J Cardiovasc Imaging, 2023, 39(2):349-357.
[19] Michelsen MM, Pena A, Mygind ND, et al. Coronary microvascular dysfunction and myocardial contractile reserve in women with angina and no obstructive coronary artery disease[J]. Echocardiography, 2018, 35(2):196-203.
[20] Nagueh SF, Smiseth OA, Appleton CP, et al. Recommendations for the evaluation of left ventricular diastolic function by echocardiography: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging[J]. Eur Heart J Cardiovasc Imaging, 2016, 17(12):1321-1360.
[21] 刘佳楠, 孙宇佳, 安换换, 等. 负荷心肌超声造影测定冠状动脉血流储备的临床应用[J]. 中国临床医学影像杂志, 2020, 31(3):180-183.
[22] Teske AJ, De Boeck BWL, Melman PG, et al. Echocardiographic quantification of myocardial function using tissue deformation imaging, a guide to image acquisition and analysis using tissue Doppler and speckle tracking[J]. Cardiovasc Ultrasound, 2007, 5:27.
[23] Rodriguez-Zanella H, Arbucci R, Fritche-Salazar JF, et al. Vasodilator strain stress echocardiography in suspected coronary microvascular angina[J]. J Clin Med, 2022, 11(3):711.
[24] Sucato V, Novo G, Madaudo C, et al. Longitudinal strain analysis and correlation with TIMI frame count in patients with ischemia with no obstructive coronary artery (INOCA) and microvascular angina (MVA)[J]. J Clin Med, 2023, 12(3): 819.
[25] 刘婷婷, 丁明岩, 孙丹丹, 等. TDI联合2D-STI评价ANOCA患者微循环功能障碍及左心功能损伤的应用价值[J]. 中华心血管病杂志, 2021, 49(12):1191-1197.
[26] Pasupathy S, Lindahl B, Litwin P, et al. Survival in patients with suspected myocardial infarction with nonobstructive coronary arteries: a comprehensive systematic review and meta-analysis from the MINOCA global collaboration[J]. Circ Cardiovasc Qual Outcomes, 2021, 14(11):e007880.
[27] Inci S, Gul M, Elcik D, et al. Identification of subclinical myocardial dysfunction by Speckle Tracking Imaging in patients with myocardial infarction with non-occlusive coronary arteries (MINOCA)[J]. Int J Cardiovasc Imaging, 2022, 38(10):2099-2106.
[28] Liu T, Wang CF, Yin J, et al. Comparison of diagnostic value between STE+LDDSE and CMR-FT for evaluating coronary microvascular obstruction in post-PCI patients for STEMI[J]. Ther Clin Risk Manag, 2022, 18:813-823.
[29] Johri AM, Chitty DW, Hua LQ, et al. Assessment of image quality in real time three-dimensional dobutamine stress echocardiography: an integrated 2D/3D approach[J]. Echocardiography, 2015, 32(3):496-507.
[30] Berbarie RF, Dib E, Ahmad M. Stress echocardiography using real-time three-dimensional imaging[J]. Echocardiography, 2018, 35(8):1196-1203.
[31] Ya?mur J, A??kg?z N, Cansel M, et al. Assessment of the left ventricular systolic function in cardiac syndrome X using speckle tracking echocardiography[J]. Anatol J Cardiol, 2016, 16(6):419-423.
[32] Ac?kgoz N, Yagmur J, Kurtoglu E, et al. Left atrial volume and function in patients with cardiac syndrome X assessed by real time three-dimensional echocardiography[J]. Echocardiography, 2017, 34(6):862-868.
[33] Yu Z, Pan H, Cheng Z, et al. Evaluation of left ventricular systolic function in patients with coronary microvascular dysfunction by three-dimensional speckle-tracking imaging[J]. Braz J Cardiovasc Surg, 2022, 37(3):321-327.

备注/Memo

备注/Memo:
通信作者：邓爱云， E-mail：540218961@qq.com
更新日期/Last Update: 2024-03-25